Inja Waldhauer

Unique carbohydrate–carbohydrate interactions are required for high affinity binding between FcγRIII and antibodies lacking core fucose

Claudia Ferrara, Sandra Grau, Christiane Jäger et al. · Proceedings of the National Academy of Sciences · 2011 · 761 citations

Pharmacy, Biochemistry, Immunology +17

Tumor-Associated MICA Is Shed by ADAM Proteases

Inja Waldhauer, Dennis Goehlsdorf, Friederike Gieseke et al. · Cancer Research · 2008 · 374 citations · Full text

Life Sciences, Immunology, Molecular Biology +15

Preclinical Activity of the Type II CD20 Antibody GA101 (Obinutuzumab) Compared with Rituximab and Ofatumumab <i>In Vitro</i> and in Xenograft Models

Sylvia Herter, Frank Herting, Olaf Mundigl et al. · Molecular Cancer Therapeutics · 2013 · 359 citations

Pharmacy, Cell Biology, Immunology +17

Cergutuzumab amunaleukin (CEA-IL2v), a CEA-targeted IL-2 variant-based immunocytokine for combination cancer immunotherapy: Overcoming limitations of aldesleukin and conventional IL-2-based immunocytokines

Christian Klein, Inja Waldhauer, Valeria Nicolini et al. · OncoImmunology · 2017 · 283 citations · Full text

Life Sciences, Immunology, Oncology +17

PD-1-cis IL-2R agonism yields better effectors from stem-like CD8+ T cells

Laura Codarri Deak, Valeria Nicolini, Masao Hashimoto et al. · Nature · 2022 · 268 citations · Full text

Life Sciences, Cancer Biology, Immunology +16